Hexter Joshua
SEC CIK 1573235 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ORMP | ORAMED PHARMACEUTICALS INC. | Chief Operating, BO | 1.07M | — | $611.4K | 14 | 2021-08-31 | 2026-07-02 |
Most active insiders at ORMP, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Hexter Joshua | COO, CBO | — | $611.4K |
| 2 | Gabay Avraham | CFO | — | $330.7K |
| 3 | Reznick Yehuda | Dir | — | — |
| 4 | Aghion Daniel | Dir | — | — |
| 5 | Shapiro Benjamin | Dir | — | — |
| 6 | Mayer Arie | Dir | — | — |
| 7 | Kidron Miriam | CSO, Dir | — | — |
| 8 | KIDRON NADAV | Pres, CEO, Dir | — | — |
Transactions 14
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-07-02 17:00 | 2026-07-01 | ORMP | ORAMED PHARMACEUTICALS INC. | Hexter Joshua | COO, CBO | S - Sale+OE | $4.46 | -137.0K | 1.02M | -12% | -$611.4K |
| D | 2026-07-02 17:00 | 2026-07-02 | ORMP | ORAMED PHARMACEUTICALS INC. | Hexter Joshua | COO, CBO | M - OptEx | $3.69 | +50.0K | 1.07M | +5% | +$184.5K |
| 2026-03-18 | 2026-03-17 | ORMP | ORAMED PHARMACEUTICALS INC. | Hexter Joshua | COO, CBO | A - Grant | $0.00 | +95.9K | 1.16M | +9% | $0 | |
| D | 2026-01-29 | 2026-01-22 | ORMP | ORAMED PHARMACEUTICALS INC. | Hexter Joshua | COO, CBO | M - OptEx | $0.00 | +19.0K | 1.06M | +2% | $0 |
| DM | 2026-01-05 | 2025-12-31 | ORMP | ORAMED PHARMACEUTICALS INC. | Hexter Joshua | COO, CBO | A - Grant | $0.00 | +212.3K | 1.05M | +25% | $0 |
| M | 2025-02-11 | 2025-02-11 | ORMP | ORAMED PHARMACEUTICALS INC. | Hexter Joshua | COO, CBO | A - Grant | $0.00 | +126.8K | 833.2K | +18% | $0 |
| 2025-01-06 | 2025-01-02 | ORMP | ORAMED PHARMACEUTICALS INC. | Hexter Joshua | COO, CBO | A - Grant | — | +194.5K | 706.3K | +38% | — | |
| 2024-11-08 | 2024-11-07 | ORMP | ORAMED PHARMACEUTICALS INC. | Hexter Joshua | COO, CBO | A - Grant | — | +30.0K | 511.8K | +6% | — | |
| 2024-01-08 | 2024-01-04 | ORMP | ORAMED PHARMACEUTICALS INC. | Hexter Joshua | COO, CBO | A - Grant | — | +180.5K | 481.8K | +60% | — | |
| 2023-05-31 | 2023-05-26 | ORMP | ORAMED PHARMACEUTICALS INC. | Hexter Joshua | COO, CBO | A - Grant | — | +27.0K | 301.3K | +10% | — | |
| 2023-04-20 | 2023-04-17 | ORMP | ORAMED PHARMACEUTICALS INC. | Hexter Joshua | COO, CBO | A - Grant | — | +108.0K | 274.3K | +65% | — | |
| 2022-08-01 | 2022-07-28 | ORMP | ORAMED PHARMACEUTICALS INC. | Hexter Joshua | COO, CBO | A - Grant | — | +42.0K | 166.3K | +34% | — | |
| D | 2022-01-05 | 2022-01-03 | ORMP | ORAMED PHARMACEUTICALS INC. | Hexter Joshua | COO, CBO | A - Grant | — | +21.0K | 124.3K | +20% | — |
| 2021-09-02 | 2021-08-31 | ORMP | ORAMED PHARMACEUTICALS INC. | Hexter Joshua | Chief Operating, BO | A - Grant | — | +33.3K | 103.3K | +48% | — |
Purchase Sale Sale after option exercise All abbreviations